Skip to content
Baker Capital StrategiesMARKETS. FILINGS. PERSPECTIVE.
Powered by THEMA

Baker Capital Strategies

Free Registration

Register for access to news, tools, alerts and reports.

THEMA Basic included at launch.

Use at least 8 characters.

Home/The Filing Wire/REGULUS THERAPEUTICS INC/ EFFECT

SEC Filing · EFFECT

REGULUS THERAPEUTICS INC

SEC Filing

Filed Jul 1, 2025Accepted Jul 1, 2025, 8:15 PM EDTCIK 1505512Accession 9999999995-25-002119
View company →Permanent SEC source ↗
Share

Company context

Historical securities (1)
RGLSNASDAQ · EQUITY · Historical · closed Jun 24, 2025

Recent company filings

  1. SCHEDULE 13G/A - filed by Point72 Asset Management, L.P. regarding Regulus Therapeutics Inc.Aug 14, 2025
  2. SCHEDULE 13G/A - filed by Deep Track Capital, LP regarding Regulus Therapeutics Inc.Aug 14, 2025
  3. 15-12G filingJul 7, 2025
  4. EFFECT filingJul 1, 2025
  5. EFFECT filingJul 1, 2025

As-filed source

Primary evidence
As filedOpen full document ↗